Karadag, Omer http://orcid.org/0000-0002-3443-3117
Dalkilic, Ediz
Ayan, Gizem
Kucuksahin, Orhan
Kasifoglu, Timucin
Yilmaz, Neslihan
Koca, Suleyman Serdar
Yazisiz, Veli
Erten, Pinar Talu
Sayarlioglu, Mehmet
Terzioglu, Mustafa Ender
Erten, Sukran
Kalyoncu, Umut
Funding for this research was provided by:
AbbVie
Article History
Received: 7 May 2021
Revised: 29 July 2021
Accepted: 23 August 2021
First Online: 3 September 2021
Declarations
:
: This study was approved by the Clinical Research Ethics Committee of Hacettepe University on October 31, 2013, with an approval number: 2013/13–03 (KA-130083).
: Written informed consent was received before enrolment from all participants.
: Not applicable.
: Omer Karadag: AbbVie (research grant, consulting fee), Pfizer (research grant, consulting fee), Roche (research grant, consulting fee), Novartis (research grant), Abdi İbrahim (consulting fee), Amgen (consulting fee), Farmanova (consulting fee), Janssen (consulting fee), Lilly (consulting fee), UCB (consulting fee). Ediz Dalkilic: AbbVie (speaker fee), MSD (speaker fee), Roche (speaker fee), Pfizer (speaker fee), UCB (speaker fee), Novartis (speaker fee). Gizem Ayan: None. Orhan Kucuksahin: None. Timucin Kasifoglu: AbbVie, Amgen, Roche, MSD, Novartis, Pfizer, and UCB (speaker and consulting fees). Neslihan Yilmaz: AbbVie (speaker fee), Pfizer (speaker fee), UCB (speaker fee), Roche (speaker fee), Janssen (speaker fee). Suleyman Serdar Koca: AbbVie (speaker fee), Pfizer (speaker fee), Roche (speaker fee), UCB (speaker fee), Novartis (speaker fee), Amgen (speaker fee), Pharmactive (speaker fee), MSD (speaker fee). Veli Yazisiz: AbbVie (consulting fee), Pfizer (consulting fee), UCB (consulting fee). Pinar Talu Erten: None. Mehmet Sayarlioglu: Genzyme (speaker fee), MSD (consulting fee), Novartis (research grant). Mehmet Ender Terzioglu: AbbVie, Pfizer, Novartis, Boehringer Ingelheim, Pharmactive, and UCB (speaker/consulting fee and/or research grant). Sukran Erten: Janssen (speaker fee), Roche (speaker fee), Novartis (speaker fee). Umut Kalyoncu: AbbVie, Pfizer (research grant, speaker, and consulting fee), Janssen (research grant, speaker fee), UCB, Novartis (speaker and consulting fee), Lilly (consulting fee).